Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
Clinical trial NCT04115306 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04115306
- Sponsor
- Phoenix Molecular Designs
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-14
- Primary completion
- 2026-12-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.